Over the past 15 years, rapid progress has been made in developmental therapeutics,
especially regarding the use of matched targeted therapies against specific oncogenic …

Background The promise of precision cancer medicine presently centers around the
genomic sequence of a patient's tumor being translated into timely, actionable information to …

Cancer cells shed naked DNA molecules into the circulation. This circulating tumor DNA
(ctDNA) has become the predominant analyte for liquid biopsies to understand the …

Aim: Next-generation sequencing (NGS) of solid tumors can inform treatment decisions;
however, uptake remains low. This objective of this systematic review was to identify barriers …

As precision medicine evolves and access to complex infectious molecular testing in the
clinical environment continues to become more widely available, the medical microbiologist …

PURPOSE Comprehensive targeted next-generation sequencing (NGS) panels are
routinely used in modern molecular cancer diagnostics. In molecular tumor boards, the …

Purpose Molecular tumor boards (MTBs) are considered beneficial for treatment decision
making for patients with cancer with uncommon, rare, or complex mutational profiles. The …

For a real impact on healthcare, precision cancer medicine requires accessibility and
interoperability of clinical and genomic data across centres and countries. Due to the …

While multidisciplinary tumor boards (MTBs) are widely used in managing patients with
cancer, their impact on patient care and outcome is not routinely measured in different …

Клиническая онкология сегодня проходит период беспрецедентных изменений.
Таргетная терапия, а в последующем иммунотерапия, революционизировали …